Nelcanen Therapeutics Overview

  • Year Founded
  • 2025

Year Founded

  • Status
  • Private

  • Employees
  • 2

Employees

  • Latest Deal Type
  • Early Stage VC

  • Investors
  • 2

Nelcanen Therapeutics General Information

Description

Developer of therapeutics designed to address conditions at the intersection of inflammation, autoimmunity, and fibrosis. The company focuses on creating novel drug candidates, advancing research programs, conducting preclinical development, exploring mechanisms of immune regulation, targeting pathways involved in chronic disease progression, and building a pipeline of therapies, enabling healthcare providers, research institutions, and patients to access innovative treatment options that aim to improve clinical outcomes, reduce disease burden, and expand therapeutic possibilities in complex immune-mediated disorders.

Contact Information

Website
www.nelcanen.com
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • Jumar Bioincubator, Level 11
  • 655 Elizabeth Street
  • Melbourne, Victoria 3000
  • Australia
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Vertical(s)
Life Sciences
Corporate Office
  • Jumar Bioincubator, Level 11
  • 655 Elizabeth Street
  • Melbourne, Victoria 3000
  • Australia

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Nelcanen Therapeutics Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
2. Early Stage VC 01-Apr-2026 Completed Startup
1. Accelerator/Incubator Completed Startup
To view Nelcanen Therapeutics’s complete valuation and funding history, request access »

Nelcanen Therapeutics Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Nelcanen Therapeutics Investors (2)

Investor Name Investor Type Holding Investor Since Participating Rounds
Uniseed Venture Capital Minority
Jumar Bioincubator Accelerator/Incubator
To view Nelcanen Therapeutics’s complete investors history, request access »

Ready to get started?

Request a free trial

Nelcanen Therapeutics FAQs

  • When was Nelcanen Therapeutics founded?

    Nelcanen Therapeutics was founded in 2025.

  • Where is Nelcanen Therapeutics headquartered?

    Nelcanen Therapeutics is headquartered in Melbourne, Australia.

  • What is the size of Nelcanen Therapeutics?

    Nelcanen Therapeutics has 2 total employees.

  • What industry is Nelcanen Therapeutics in?

    Nelcanen Therapeutics’s primary industry is Drug Discovery.

  • Is Nelcanen Therapeutics a private or public company?

    Nelcanen Therapeutics is a Private company.

  • What is Nelcanen Therapeutics’s current revenue?

    The current revenue for Nelcanen Therapeutics is .

  • Who are Nelcanen Therapeutics’s investors?

    Uniseed and Jumar Bioincubator have invested in Nelcanen Therapeutics.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process